Trial Will Assess Safety, Efficacy of New DBS Feature for Percept PC Device
Medtronic has launched a clinical trial to assess the safety and efficacy of adaptive deep brain stimulation, or aDBS, an investigational feature of its Percept PC Neurostimulator device, in people with Parkinson’s disease. Unlike conventional continuous deep brain stimulation, known as cDBS — in which electrical signals…